Golimumab (Anti-TNFSF2 / TNFa) | TNF-alpha antibody | Read Reviews & Product Use Citations

Golimumab (Anti-TNFSF2 / TNFa) is a human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. MW: 146.94 KD.

Purity & Quality Control

Batch: A289201 Purity: 99% Protein concentration: 3.54mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective TNF-alpha Inhibitors

Biological Activity

Description	Golimumab (Anti-TNFSF2 / TNFa) is a human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. MW: 146.94 KD.

References
[1] Shealy DJ, et al. MAbs. 2010;2(4):428-439.

References

[1] Shealy DJ, et al. MAbs. 2010;2(4):428-439.

Product Details

CAS No.	476181-74-5
Molecular Weight	146.94
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field